Skip to content
Abierto
Menu

Award notice

Bupropion HCL ER

SPE2D2-23-D-0002

Defense Logistics Agency, DLA Troop Support. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

RADHA PHARMACEUTICALS Inc. Hauppauge

$23,278,523.95 on the award notice, October 6, 2022, contract SPE2D2-23-D-0002

Description

As published on SAM.gov.

Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract. Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract.

Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation. Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract. Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 14, 2026

    Award notice

    Awarded to RADHA PHARMACEUTICALS Inc. Hauppauge for $23,278,524. SAM.gov, notice 885609e0a0a44507927f0fb893d641d5

Points of contact

Also open from this buyer